|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
20 Acorn Park Dr, STE 400, Cambridge, Massachusetts 02140, US
|
|
Omega Therapeutics ™ is a privately-held, development-stage biotechnology company pioneering the field of epigenomic programming to precisely regulate and control the human genome to treat and cure disease. Omega’s breakthrough science has enabled it to tap into nature’s universal operating system that epigenetically controls the human genome, to target the most fundamental genomic processes which fuel cellular growth, differentiation, and gene expression.
Omega Therapeutics was founded by Flagship Pioneering in 2017 and currently has eight programs in various stages of preclinical development. The Company is strategically pursuing specific disease targets that have not been successfully addressed through conventional modalities, including certain oncology indications, liver disease, serious inflammatory conditions, and acute respiratory distress syndrome (ARDS), among others. Omega’s mission is to transform medicine and deliver the therapies of tomorrow.
|
Omega Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75%
|
The widely used Omega Therapeutics email format is {f}{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Omega Therapeutics customer service number in your country click here to find.
Mahesh Karande is the CEO of Omega Therapeutics. To contact Mahesh Karande email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.